| Bortezomib and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors (NCT00541359) | City of Hope Medical Center | 2004-01-01 |
| Bevacizumab in Treating Patients With Advanced Solid Tumors (NCT00416637) | Herbert Hurwitz, MD | 2004-01-01 |
| Investigation Into the Safety of Intradermal Juvidex (M6P) Administered to Wounds of Healthy Subjects (NCT00984854) | Renovo | 2004-01-01 |
| Stem Cell Study for Patients With Heart Disease (NCT00081913) | Losordo, Douglas, M.D. | 2004-01-01 |
| Expiratory Muscle Training in Patients With Parkinson's Disease (NCT00843739) | University of Florida | 2004-01-01 |
| Inspiratory Muscle Training After Gastroplasty (NCT01084447) | University of Sao Paulo | 2004-01-01 |
| Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma (NCT00078637) | Eisai Inc. | 2004-01-01 |
| Safety and Tolerability of Rituximab in Neuromyelitis Optica (NCT00501748) | University of California, San Francisco | 2004-01-01 |
| A Pilot Therapeutic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy Patients (NCT00568802) | Stanford University | 2004-01-01 |
| Phase 1 Pilot Study of an ART Bridging Regimen in Highly Experienced Patients Unable to Achieve Viral Suppression (NCT00336778) | University of Maryland, Baltimore | 2004-01-01 |
| Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia (NCT00244829) | Fred Hutchinson Cancer Center | 2004-01-01 |
| A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration (NCT00090532) | Pfizer | 2004-01-01 |
| RNA-Loaded Dendritic Cell Cancer Vaccine (NCT00087984) | Argos Therapeutics | 2004-01-01 |
| Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine (NCT00164411) | Centers for Disease Control and Prevention | 2004-01-01 |
| Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer (NCT00086957) | City of Hope Medical Center | 2004-01-01 |
| A Pilot Study of Pivanex in Patients With Malignant Melanoma (NCT00087477) | Titan Pharmaceuticals | 2004-01-01 |
| Study of Bexarotene in Patients With Acute Myeloid Leukemia (NCT00316030) | Abramson Cancer Center at Penn Medicine | 2004-01-01 |
| 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome (NCT00077558) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-01-01 |
| Effect of Cytochrome P 450 3A4 Inhibition by Itraconazole on the Single Oral Dose Pharmacokinetics of Cilobradine (NCT02264041) | Boehringer Ingelheim | 2004-01-01 |
| Safety, Tolerance, and Pharmacokinetics of Single Rising Oral Doses of BILB 1941 ZW Solution in Healthy Male Subjects, Followed With Bioavailability Comparison of BILB 1941 ZW Tablet and Solution Formulation Administered With or Without Food (NCT02256787) | Boehringer Ingelheim | 2004-01-01 |
| Bupropion and Cigarette-Related Cues in Smokers (NCT03920319) | University of California, Los Angeles | 2004-01-01 |
| Occipital Nerve Stimulation to Treat Chronic Headaches (NCT00205894) | Boston Scientific Corporation | 2004-01-01 |
| Pharmacodynamic Effects, Safety and Tolerability of Cilobradine, to Healthy Male and Female Volunteers, With an Intra-individual Comparison to Moxifloxacin in a Subset of Volunteers (NCT02264015) | Boehringer Ingelheim | 2004-01-01 |
| Imatinib in Dermatofibrosarcoma Protuberans (DFSP) (NCT00122473) | Dermatologic Cooperative Oncology Group | 2004-01-01 |
| Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM) (NCT00116376) | Novartis Pharmaceuticals | 2004-01-01 |
| Bacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder Cancer (NCT00696579) | University Of Perugia | 2004-01-01 |
| Dose Reduction in Thoracic CT (NCT00188461) | University Health Network, Toronto | 2004-01-01 |
| A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting Conditions (NCT00865748) | Actavis Inc. | 2004-01-01 |
| Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle Study (NCT01046253) | Teva Pharmaceuticals USA | 2004-01-01 |
| Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions (NCT01149486) | Teva Pharmaceuticals USA | 2004-01-01 |
| Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast Cancer (NCT00093834) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-01-01 |
| Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer (NCT00087334) | Roswell Park Cancer Institute | 2004-01-01 |
| 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies (NCT00077181) | National Cancer Institute (NCI) | 2004-01-01 |
| A Phase Ib, Open-label, Multicenter Study of the Safety and PK of the Combination of rhuMAb2c4 (Omnitarg), a Recombinant Humanized Antibody to HER2, and Capecitabine (Xeloda) in Patients With Advanced Solid Tumors (NCT02494596) | Hoffmann-La Roche | 2004-01-01 |
| Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NCT00082823) | Regeneron Pharmaceuticals | 2004-01-01 |
| Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease (NCT00136396) | Dana-Farber Cancer Institute | 2004-01-01 |
| Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy (NCT00188383) | University Health Network, Toronto | 2004-01-01 |
| Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NCT00083213) | Regeneron Pharmaceuticals | 2004-01-01 |
| Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia (NCT00081822) | University of Alabama at Birmingham | 2004-01-01 |
| Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fasting Conditions (NCT00804440) | Perrigo Company | 2004-01-01 |
| Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy (NCT00100256) | Andarix Pharmaceuticals | 2004-01-01 |
| A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1 (NCT00267657) | National Institute on Drug Abuse (NIDA) | 2004-01-01 |
| Effect of, OAT3, on the Renal Secretion of Cefotaxime (NCT00187655) | University of California, San Francisco | 2004-01-01 |
| Placebo-controlled Assessment of the Effect of a Food Supplement on Skin Protection After Exposure to UV Radiation (NCT00351689) | L'Oreal | 2004-01-01 |
| Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative Colitis (NCT00267306) | Facet Biotech | 2004-01-01 |
| Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein (NCT00529698) | Istituto Superiore di Sanità | 2004-01-01 |
| Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer (NCT00079300) | National Naval Medical Center | 2004-01-01 |
| Phase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHL (NCT00151320) | Weill Medical College of Cornell University | 2004-01-01 |
| Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer (NCT02007005) | Abnoba Gmbh | 2004-01-01 |
| Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia (NCT00077467) | National Cancer Institute (NCI) | 2004-01-01 |
| The Effect of Lopinavir/Ritonavir on Endothelial Function (NCT00076414) | National Institutes of Health Clinical Center (CC) | 2004-01-01 |
| Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine Given to PPD-Negative Adults (NCT00730795) | GlaxoSmithKline | 2004-01-01 |
| Therapeutic Effects of Berberine in Patients With Type 2 Diabetes (NCT00425009) | Shanghai Jiao Tong University School of Medicine | 2004-01-01 |
| Health of Young European Families and Fish Consumption (NCT00315770) | Landspitali University Hospital | 2004-01-01 |
| Effect of Soy Bread on Markers of Bone Metabolism and Cardiovascular Disease (NCT00366860) | University of Michigan | 2004-01-01 |
| Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer (NCT00456989) | University of Louisville | 2004-01-01 |
| Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC) (NCT00082472) | Zivena | 2004-01-01 |
| Tipifarnib and Radiation Therapy in Treating Young Patients With Brainstem Glioma (NCT00079339) | National Cancer Institute (NCI) | 2004-01-01 |
| Cutaneous Effects of Cryogen Spray Cooling (NCT00581568) | University of California, Irvine | 2004-01-01 |
| Bioequivalence Study of Rivastigmine 1.5 mg Capsules Under Fasting Conditions (NCT01146067) | Dr. Reddy's Laboratories Limited | 2004-01-01 |
| Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma (NCT00506779) | M.D. Anderson Cancer Center | 2003-12-29 |
| Infliximab to Treat Non-Infectious Scleritis (NCT00075075) | National Eye Institute (NEI) | 2003-12-23 |
| Safety and Tolerability Study of FG-3019 in Participants With Idiopathic Pulmonary Fibrosis (NCT00074698) | Kyntra Bio | 2003-12-08 |
| Pantoprazole Sodium 40 mg DR Tablets Under Fasting Conditions (NCT00835588) | Teva Pharmaceuticals USA | 2003-12-01 |
| Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early Onset Type I Diabetes Mellitus (NCT00315133) | University of Sao Paulo | 2003-12-01 |
| Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting Conditions (NCT00835393) | Teva Pharmaceuticals USA | 2003-12-01 |
| Boronophenylalanine (BPA)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment Head and Neck Tumors (NCT00114790) | Boneca Corporation | 2003-12-01 |
| A Trial Of SU14813 In Patients With Advanced Solid Malignancies (NCT00982267) | Pfizer | 2003-12-01 |
| Bevacizumab in Treating Young Patients With Refractory Solid Tumors (NCT00085111) | National Cancer Institute (NCI) | 2003-12-01 |
| CP-751,871 Treatment For Patients With Multiple Myeloma (NCT01536145) | Pfizer | 2003-12-01 |
| Treatment of In-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR I) (NCT00106587) | University Hospital, Saarland | 2003-12-01 |
| Safety, Tolerability and Pharmacokinetics of Single Rising and Multiple Oral Doses of Telmisartan / Hydrochlorothiazide (HCTZ) in Healthy Male Volunteers (NCT02262780) | Boehringer Ingelheim | 2003-12-01 |
| Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected Adults (NCT00249106) | International AIDS Vaccine Initiative | 2003-12-01 |
| Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria (NCT00075049) | U.S. Army Medical Research and Development Command | 2003-12-01 |
| Tissue-Type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events (MACE) in Patients With Non-critical Coronary Artery Disease (NCT00868855) | Vanderbilt University | 2003-12-01 |
| Food Study Metformin Hydrochloride ER Tablets 750 mg and Glucophage XR 750 mg (NCT00649350) | Mylan Pharmaceuticals Inc | 2003-12-01 |
| Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma (NCT00185861) | Stanford University | 2003-12-01 |
| A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Multiple Myeloma (0683-004) (NCT00109109) | Merck Sharp & Dohme LLC | 2003-12-01 |
| Rituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHL (NCT00077961) | Genzyme, a Sanofi Company | 2003-12-01 |
| Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected Adults (NCT00069030) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-12-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Rheumatoid Arthritis With Ongoing Treatment With Methotrexate (NCT00619905) | Novartis | 2003-12-01 |
| Effectiveness of Brainwave Biofeedback in the Treatment of Fibromyalgia (NCT00080184) | National Center for Complementary and Integrative Health (NCCIH) | 2003-12-01 |
| ZD1839 With Hypofractionated Radiation Therapy With an Immobilization Device for Advanced Non-Small Cell Lung Cancer (NCT00328562) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2003-12-01 |
| Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic Malignancies (NCT00113048) | Genzyme, a Sanofi Company | 2003-12-01 |
| Pivotal Bioequivalence Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult Subjects (NCT00865605) | Actavis Inc. | 2003-12-01 |
| Citrulline for Children Undergoing Cardiopulmonary Bypass Surgery (NCT00201214) | Vanderbilt University | 2003-12-01 |
| Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT00071136) | Eli Lilly and Company | 2003-12-01 |
| Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma (NCT00075634) | National Cancer Institute (NCI) | 2003-12-01 |
| CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas (NCT00074243) | National Cancer Institute (NCI) | 2003-12-01 |
| Health Behavior Feedback Study for Veterans With Hepatitis C (NCT00229580) | University of Washington | 2003-12-01 |
| Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium (NCT00082719) | M.D. Anderson Cancer Center | 2003-12-01 |
| Bioavailability Study of Leflunomide Tablets Under Fed Conditions (NCT00653003) | Par Pharmaceutical, Inc. | 2003-12-01 |
| Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV Vaccine (NCT00482027) | International AIDS Vaccine Initiative | 2003-12-01 |
| Bioequivalence Study of Dr.Reddys Laboratories Limited, Glimepiride 1 mg Tablets in Healthy Subjects Under Fed Condition (NCT01053689) | Dr. Reddy's Laboratories Limited | 2003-12-01 |
| Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT00077155) | National Cancer Institute (NCI) | 2003-12-01 |
| Safety of CHIR-258 (TKI258) in Advanced Solid Tumors (NCT01270906) | Novartis Pharmaceuticals | 2003-12-01 |
| Bioequivalence Study of Dr.Reddy's Laboratories Limited, Glimepiride Tablets 1 mg Under Fasting Condition (NCT01052909) | Dr. Reddy's Laboratories Limited | 2003-12-01 |
| Phase I Safety and Immunogenicity Vaccine Trial Against HIV/AIDS (NCT00505401) | Istituto Superiore di Sanità | 2003-12-01 |
| Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis (NCT00282438) | Northwestern University | 2003-12-01 |
| Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer. (NCT00209716) | Hokkaido Gastrointestinal Cancer Study Group | 2003-12-01 |